Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
Hannah Kelly, Brent S. Sokola, Hesham Abboud
Topics & Concepts
FingolimodTeriflunomideMedicineAlemtuzumabGlatiramer acetateMultiple sclerosisNatalizumabOcrelizumabImmunologyVaccinationRituximabVirologyLymphomaAntibodySARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders